更新了关于小分子在调解蛋白质降解中的作用的综述
Zumei Wu1, Yulong Li1, Jinyun Dong2
1School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
European journal of medicinal chemistry
|February 11, 2025
概括
向蛋白质降解 (TPD) 通过劫持细胞机械来破坏蛋白质,为药物开发提供了新的途径. 这种方法扩大了药物标,提高了选择性,彻底改变了生物研究和药物发现.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 传统药物开发的目标是蛋白质活性部位.
- 有针对性的蛋白质降解 (TPD) 使用细胞降解途径.
- TPD提供了诸如提高效率和更广泛的目标范围等优势.
研究的目的:
- 审查目前的针对性蛋白质降解 (TPD) 策略.
- 讨论TPD设计概念,好处和挑战.
- 为药物设计和临床应用提供见解.
主要方法:
- 审查关于TPD策略的现有文献.
- 对TPD机制的分析,包括PROTAC,PROTAB和AUTOTAC.
- 专注于乌比奎丁-蛋白酶体和溶酶体降解途径.
主要成果:
- TPD策略利用细胞破坏机制.
- 通过TPD,可以准以前无法药物治疗的蛋白质.
- 已经出现了各种TPD方法,如PROTAC,PROTAB和AUTOTAC等.
结论:
- TPD代表了药物发现的重大进步.
- 这些策略为生物研究提供了新的方法.
- 进一步开发有望为未来的临床应用提供希望.
相关概念视频
Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
The Proteasome
8.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.5K
Regulation of Expression at Multiple Steps
864
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
864
Proteins: From Genes to Degradation
11.9K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
11.9K
mRNA Stability and Gene Expression
5.5K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
Cis-acting Elements involved in mRNA stability
5.5K
Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K


